代谢疾病Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents.
期刊：The Journal of pharmacology and experimental therapeutics发表年份：2007作者：Tung M Fong; Xiao-Ming Guan; Donald J Marsh; Chun-Pyn Shen; D Sloan Stribling; Kim M Rosko; Julie Lao; Hong Yu; Yue Feng; Jing C Xiao; Lex H T Van der Ploeg; Mark T Goulet; Williams K Hagmann; Linus S Lin; Thomas J Lanza; James P Jewell; Ping Liu; Sh
